Leadership Overview
UBC has 4 executives leading key functions including corporate strategy, human capital management, operational oversight, and legal compliance.
Focused on advancing biopharmaceutical evidence development, UBC delivers critical real-world data solutions to support the safety, efficacy, and value assessment of medical products for global life sciences organizations.
Focused on advancing biopharmaceutical evidence development, UBC delivers critical real-world data solutions to support the safety, efficacy, and value assessment of medical products for global life sciences organizations.
Leadership Roles at UBC
Bekki Brown - President & Chief Executive Officer
Bekki Brown, the President & Chief Executive Officer at UBC, directs the overarching strategic vision for the organization. Brown architects the integration of scientific expertise with advanced data analytics to address complex drug development challenges. By overseeing global operations, the President & Chief Executive Officer ensures that biopharmaceutical clients receive high-quality evidence development solutions. This leadership role involves constant collaboration with the Board to maintain market leadership in real-world evidence generation. Bekki Brown drives the company mission to support the safety and efficacy of medical products under real-world conditions. Through rigorous oversight of commercialization strategies, the President & Chief Executive Officer secures long-term growth and operational excellence. Brown maintains a focus on expanding the reach of evidence-based services across international markets, ensuring that the organization remains a trusted partner for life sciences companies navigating regulatory and payer decision-making landscapes.
Dean Reiman - President
Dean Reiman, the President at UBC, oversees the execution of core operational functions related to evidence development and commercialization services. Reiman directs the delivery of specialized solutions that support the safety and value assessment of medical products. By managing cross-functional teams, the President ensures that scientific expertise remains integrated with technology-driven platforms to provide actionable insights for life sciences organizations. This leadership role involves driving operational efficiency to meet the rigorous demands of regulatory and payer stakeholders. Dean Reiman focuses on scaling service delivery models to accommodate the increasing complexity of global drug development. Through the coordination of internal resources, the President supports the company's commitment to generating meaningful real-world evidence. Reiman maintains a strategic focus on operational excellence, ensuring that the organization consistently delivers high-value outcomes that inform critical healthcare decision-making processes across diverse international markets.
Lakshana Pujar - Chief Human Resources Officer
Lakshana Pujar, the Chief Human Resources Officer at UBC, manages the global talent strategy required to support complex biopharmaceutical service delivery. Pujar architects organizational development initiatives that align workforce capabilities with the company's advanced data analytics and scientific platforms. Overseeing recruitment, retention, and professional growth, the Chief Human Resources Officer ensures that the organization attracts top-tier experts in clinical and real-world evidence. This leadership role involves fostering a culture of innovation that supports the company's mission to improve healthcare decision-making. Lakshana Pujar drives internal efficiency by implementing scalable human capital systems across all regional operations. By optimizing employee engagement and performance management, the Chief Human Resources Officer directly impacts the ability of the company to meet the evolving needs of pharmaceutical clients. Pujar secures the organizational foundation necessary for sustained growth and excellence in the competitive life sciences services sector.
Michael Haratz - Senior Vice President, Chief Legal Officer
Michael Haratz, the Senior Vice President, Chief Legal Officer at UBC, manages all legal, regulatory, and compliance frameworks governing the organization's biopharmaceutical services. Haratz architects risk mitigation strategies that protect the integrity of real-world evidence generation and data analytics operations. Overseeing corporate governance, the Senior Vice President, Chief Legal Officer ensures that all service delivery models align with global regulatory standards and healthcare industry requirements. This leadership role involves providing critical counsel to the executive team regarding complex legal challenges in drug development and commercialization. Michael Haratz drives the development of robust compliance programs that support the company's mission to provide reliable evidence for payer and regulatory decision-making. By navigating the intricate legal landscape of the life sciences sector, the Senior Vice President, Chief Legal Officer secures the operational stability of the company. Haratz maintains a focus on ethical standards and legal excellence across all global business activities.
Explore Leadership Teams in Business Services
Founded in 1984, MIMOS is Malaysia’s national Applied Research and Development Centre. As a strategic agency under the Ministry of Science, Technology And Innovation (MOSTI). MIMOS contributes to transforming Malaysia’s industry through patentable technology platforms, products, and solutions. MIMOS hosts six national technology facilities and renders technical and consultancy services. The facilities serve as a technology reference center that promotes open innovation and the creation of tailored solutions to challenges faced by the government and industry. The company is headquartered in Kuala Lumpur, Malaysia.
Company Leadership MY
The Urban Institute operates as a nonpartisan research organization committed to generating rigorous analysis and evidence-based insights on critical social and economic policy questions. Through empirical research and data-driven investigation, the organization works to inform public discourse and guide policymakers toward solutions that address complex societal challenges. The institute's work spans multiple dimensions of policy analysis, examining issues that directly affect communities and individuals across diverse socioeconomic circumstances. The organization maintains a multidisciplinary approach to research, bringing together economists, social scientists, and policy experts who collaborate to produce comprehensive studies and evaluations. This collaborative model enables the institute to examine interconnected policy challenges from multiple perspectives, generating nuanced findings that reflect the complexity of real-world problems. The research teams conduct original data collection, statistical analysis, and longitudinal studies designed to track outcomes and measure the effectiveness of various policy interventions. Urban Institute research addresses a broad spectrum of policy domains, including economic opportunity, education systems, health care access, housing markets, and government effectiveness.
Company Leadership JP
NASA Jet Propulsion Laboratory, located in Pasadena, California, is a federally funded research and development center and NASA field center that specializes in the construction and operation of robotic planetary spacecrafts for Earth-orbit and astronomy missions and is also responsible for operating NASA's Deep Space Network.
Company Leadership MJ
JC
RA
WuXi Biologics, founded in 2014 and headquartered in China, provides integrated technology platforms for biologics drug development.
Company Leadership JL
JG
SG
Frequently Asked Questions Regarding UBC Top Executives and Leadership Team
